At the IHC level, Chowdhury et al. showed that strong p53 expression was much more frequent in high-grade and higher-stage urothelial carcinomas than in low-grade tumors, with a higher frequency in the MIBC vs. NMIBC subgroup, consistent with our findings [14]. Here, TP53 is linked to urothelial carcinoma.